Cabozantinib CAS No. 849217-68-1 Pharmaceutical Intermediates
overview
Cabozantinib is an oral medication that belongs to the class of targeted therapies used in the treatment of various cancers, including advanced renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).
Cabozantinib works by inhibiting multiple receptor tyrosine kinases, including MET, VEGFR, and AXL, which play critical roles in tumor growth, angiogenesis, and metastasis.
Its unique mechanism of action makes it a valuable option in the management of advanced cancer.
Physical and Chemical Properties
- Solubility: Soluble in dimethyl sulfoxide (DMSO) and slightly soluble in water, facilitating its incorporation into various pharmaceutical formulations.
- Melting Point: Approximately 150-155 °C, making it suitable for various storage and application conditions.
- Stability: Exhibits good stability under standard laboratory conditions, with a shelf life that allows for extended use without significant degradation.
These properties make Cabozantinib an ideal candidate for incorporation into various pharmaceutical formulations, where stability and solubility are critical for patient compliance and therapeutic effectiveness.
1. Multi-Targeted Action: By inhibiting multiple receptor tyrosine kinases, Cabozantinib effectively disrupts various pathways involved in cancer progression, providing a comprehensive approach to treatment.
2. Proven Efficacy: Clinical trials have demonstrated the effectiveness of Cabozantinib in improving overall survival rates in patients with advanced RCC and HCC.
3. Oral Administration: The oral formulation of Cabozantinib allows for convenient administration, improving patient adherence to treatment regimens.
4. Reduced Side Effects: Compared to traditional chemotherapy, Cabozantinib has a more favorable side effect profile, making it a more tolerable option for patients.
As a foreign trade company specializing in pharmaceutical ingredients, we understand the importance of high-quality laboratory instrumentation and consumables in the research and development of Cabozantinib and its applications. Our offerings include:
- High-Performance Liquid Chromatography (HPLC) Systems: Essential for the analysis and quality control of Cabozantinib and its formulations.
- Mass Spectrometers: Used for the precise identification and quantification of Cabozantinib in various formulations.
- Refrigerated Centrifuges: Ideal for the separation of reaction mixtures and purification of products containing Cabozantinib.
- Customizable Lab Consumables: We provide a range of lab consumables tailored to meet the specific needs of our clients, ensuring seamless integration into their research processes.
In conclusion, Cabozantinib is a vital compound in the field of oncology, particularly for its role in treating advanced renal cell carcinoma and hepatocellular carcinoma.
Its unique physical and chemical properties, combined with its multi-targeted action and proven efficacy, make it a preferred choice for healthcare professionals.
By choosing Cabozantinib, you are not only investing in a superior product but also in the health and well-being of patients who rely on effective cancer treatment options.
As a reliable supplier, we are committed to providing high-quality Cabozantinib and supporting laboratory instrumentation to enhance your research and development efforts. Partner with us for timely delivery, exceptional service, and a commitment to quality that you can trust.
Contact us today to learn more about our offerings and how we can support your pharmaceutical needs.